http://www.medicalnewstoday.com/articles/83618.php
Genetic Differences Predict Anti Inflammatory Benefits From
Nutritional Products
Article Date: 26 Sep 2007 - 0:00 PDT
Interleukin Genetics (Amex: ILI) reported in the journal Nutrition
that a botanical supplement reduced inflammation more effectively in
individuals with genetic variations that are associated with over
expression of inflammation and risk for early heart attacks. This is
one of few studies that recruited study subjects who have different
genetic patterns and tested how they responded to nutritional products
or drugs.
The study examined healthy individuals with raised inflammation levels
and their response to a 12 week course of botanical treatment. The
study found that patients who tested positive for at-risk IL-1 gene
variations were more likely to show a decrease in inflammation after
botanical treatment than those who tested negative for the IL-1 gene
variations. The genetic test identifies people who tend to over-
produce IL-1, a powerful mediator of the inflammatory response, and
have an increased risk for early heart attacks. The botanical product
used in the study was developed by Access Business Group International
LLC (an affiliate of Interleukin's majority stockholder, Alticor
Inc.), after screening hundreds of plant extracts in the laboratory
for their ability to reduce IL-1 production.
...